Chief Executive Officer at Newton Biocapital
Check size: Newton Biocapital does not publish a standard current check-size range on its official site.
Alain Parthoens is listed in a Chief Executive Officer capacity at Newton Biocapital. The firm does not publish a person-specific investment thesis for this role; the profile preserves the role distinction and uses the firm's mandate only as shared context.
Present the unmet need, evidence, intellectual property, regulatory and clinical plan, team and Europe-Japan opportunity.
Strong science, experienced teams and differentiated healthcare products with credible development and internationalization paths.
Opportunities outside life sciences or without evidence of unmet need, differentiation and development feasibility are less aligned.